Brief low-workload myocardial ischaemia induces protection against exercise-related increase of platelet reactivity in patients with coronary artery disease Giancarla Scalone, Ilaria Coviello, Lucy Barone, Chiara Pisanello, Alfonso Sestito, Gaetano A Lanza, Filippo Crea ABSTRACT Objective In patients with acute myocardial infarction, pre-infarction angina is associated with smaller infarct size, probably mainly through myocardial protection induced by ischaemic preconditioning. However, in models of recurrent thrombosis myocardial ischaemia also improves arterial patency. This study investigated whether myocardial ischaemia has any effect on platelet function in patients with coronary artery disease. Patients and design Twenty patients with lowworkload myocardial ischaemia underwent, in a randomised crossover study, two treadmill exercise stress tests (EST) on two separate days: a single maximal EST (EST-1) and a maximal EST (EST-2) performed 45 minutes after a low-workload EST stopped at 1-mm ST depression (p-EST). Platelet reactivity was evaluated by measuring the closure time in response to ADP/collagen by the PFA-100 method, and monocyteeplatelet aggregate (MPA) formation and CD41 platelet expression, with and without ADP stimulation, by flow cytometry. Results Compared to resting values, closure time decreased at peak EST-1 (p<0.001) but not at peak EST-2. MPA after ADP stimulation increased more significantly at peak EST-1 compared with peak EST-2 (p<0.001). Repetition in seven patients of the pEST/ EST-2 protocol after intravenous administration of the adenosine antagonist theophylline showed prevention of the effects of p-EST on exercise-induced platelet reactivity. Conclusions A short episode of myocardial ischaemia induces protection against an exercise-induced increase of platelet reactivity. These data also suggest a role for adenosine in this phenomenon.
Experimental studies have shown that brief episodes of myocardial ischaemia induce protection against myocardial injury caused by a subsequent prolonged ischaemic insult by determining metabolic changes in myocardial cells, which make them more resistant to ischaemia, a phenomenon called 'ischaemic preconditioning'. 1 2 In clinical practice, myocardial protection by ischaemic preconditioning is believed to play a role in mediating the beneficial effects of pre-infarction angina in patients presenting with acute myocardial infarction (AMI). 3 4 Moreover, patients with prodromal angina, compared with those without, have also been shown to present a higher rate of successful coronary reperfusion following thrombolytic therapy, 5 6 suggesting that pre-infarction angina might also be associated with a lower thrombogenic condition. Accordingly, experimental studies have shown that transient myocardial ischaemia may attenuate platelet reactivity and aggregability to damaged coronary artery vessel walls, suggesting that in the clinical setting the favourable effects of preconditioning might also be mediated by a reduction in platelet reactivity. 7 8 In any case, no previous study has assessed the effect of ischaemic preconditioning on platelet reactivity in patients.
Exercise is known to enhance platelet aggregability in patients with obstructive coronary artery disease (CAD).
9e13 At the same time, it is known that in CAD patients an exercise stress test (EST) performed within 30 minutes of a previous positive test shows an improvement of ischaemic changes, suggesting an ischaemic preconditioning effect by the first test. In this study we assessed whether mild transient myocardial ischaemia induced by exercise can prevent the increase of platelet reactivity in subsequent maximal efforts.
METHODS

Study groups
We studied 20 patients who fulfilled the following inclusion criteria: (1) a stable pattern of angina pectoris for more than 6 months; (2) ST-segment depression at low workload (less than 1st stage of Bruce protocol) during electrocardiographic (ECG) EST; (3) significant stenosis (>75% of the lumen diameter) in at least one of the major epicardial coronary arteries. All patients were taking aspirin (100 mg). Patients were excluded if they were unable to perform EST, had ECG alterations that could interfere with ST-segment analysis (eg, bundle branch block, pacemaker rhythm, abnormal ST changes at rest), or were taking anticoagulant drugs. A careful clinical history, including cardiovascular risk factors and drug therapy, was recorded from each patient. All patients gave informed consent for participation in the study. The study complied with the Declaration of Helsinki and was approved by the institutional review board of our institute.
Exercise stress test
A scheme of the study protocol is shown in figure 1 . Patients underwent, in a randomised crossover design, two ESTseparated by a 4-day interval. In one case patients underwent maximal treadmill EST (control EST, or EST-1). In the other case, patients underwent a low workload EST, which was stopped at the ischaemia threshold, ie, within 15 s of the appearance of 1-mm ST-segment depression in any lead (preconditioning EST or p-EST); this EST was followed, 45 minutes later, by a maximal EST (preconditioned EST, or EST-2).
EST were always performed in the afternoon according to standard Bruce protocol. Leads II, V2 and V5 were monitored continuously; a 12-lead ECG was printed at the end of each stage, when clinically indicated and at 1-minute intervals in the recovery phase. Blood pressure was measured at baseline, during the last minute of each stage and at peak exercise. EST-1 and EST-2 were stopped in the case of: (1) physical exhaustion; (2) ST-segment depression of 3 mm or greater; (3) progressive angina (Borg scale $6); (4) relevant clinical events (eg, dyspnoea, hypotension, arrhythmias). ST-segment depression was considered significant if it was horizontal or downsloping and 1 mm or greater at 0.08 s from the J point.
Blood sampling
In all patients blood samples were obtained immediately before each EST and within 5 minutes of peak EST-1 and EST-2 (figure 1). Through a clean, non-traumatic venipuncture, and with minimal venous occlusion, samples were drawn directly into plastic tubes containing 0.106 M trisodium citrate (blood : citrate 9 : 1), after discarding the first 2 ml to minimise the formation of platelet aggregates. 17 Blood was kept at room temperature and assayed within 1 h for platelet function analysis by an expert technician. An aliquot was used within 10 minutes of collection to prepare samples for analysis by flow cytometry.
Platelet reactivity
Platelet reactivity was assessed by the platelet function analyser system (PFA-100; Dade Behring, Milan, Italy), in which the process of primary haemostasis (platelet adhesion and aggregation following vascular injury) is simulated ex vivo. Details about this method have been described elsewhere.
18e21 Briefly, 800 ml of anticoagulated whole blood is added to a standardised disposable cartridge and incubated at 38.58C. The blood is then aspirated under arterial shear rates (5000 s À1 ) through a microscopic ring coated with collagen (2 mg equine type 1 collagen) and ADP (50 mg). Platelets flowing through the ring are activated and adhere to each other to form an aggregate, thus gradually diminishing and finally stopping the blood flow. The time to reach ring occlusion (closure time), is taken as a measure of platelet reactivity (adhesion and aggregation), with shorter times indicating greater reactivity. Duplicate measures of closure time performed randomly in 10 samples showed differences of less than 5%, in agreement with our previous studies showing good reproducibility of closure time measurements. 20 21 Flow cytometry
Monocyteeplatelet aggregates
Blood (100 ml) was labelled within 10 minutes of collection with a saturating concentration of PerCP-conjugated CD14 (lipopolysaccharide protein receptor) and FITC-conjugated glycoprotein IIb/IIIa (GP IIb CD41) for 15 minutes at room temperature. Following incubation, erythrocytes were lysed with buffered ammonium chloride and analysed by FACScan. Monocyteeplatelet aggregates (MPA) were identified using the logical gating facility by a combination of binding characteristics of anti-CD14 (monocyte marker) and of anti-CD41 (platelet marker) antibodies. A minimum of 3000 monocytes was counted for each test. MPA were expressed as a percentage of monocyte binding platelets and as mean fluorescence intensity of CD41 (CD41-mfi) in the monocyteeplatelet gate.
12
Stimulation with ADP
The response to ADP stimulation of MPA formation and CD41 expression in the monocyteeplatelet gate was also assessed. To this aim, blood samples were incubated with ADP (final concentrations 10 À7 M) for 15 minutes at room temperature and labelled and analysed as previously described. 12 
Theophylline infusion
In the last seven patients (7265 years, six men) the pEST/EST-2 protocol was repeated with the aim of evaluating whether adenosine could be involved in the effect of pEST on platelet reactivity. This non-randomised part of the study was carried out 23.464 days after the second test. The exercise/sampling protocol was repeated after the administration of the nonspecific adenosine receptor antagonist theophylline (240 mg in 100 ml of saline, infused intravenously over 30e45 minutes). 19 At the end of infusion, according to the established protocol (figure 1), patients underwent a low-workload EST stopped at the ischaemia threshold (preconditioning EST-Th), followed 45 minutes later by a sign/symptoms limited EST (preconditioned EST-Th).
Statistics
According to the KolmogoroveSmirnov test, variables assessed in the study showed a distribution not significantly different from normal, and were then analysed using parametric tests.
According to previous studies, we hypothesised that in these patients a 20% decrease in closure time could occur after EST-1. By assuming as significant at a p level of 0.05 a reduction of the decrease of 80% after EST-2 (ie, a closure time decrease of only 4 s or less), we calculated that 20 patients were necessary to have a power of 60% to detect the difference.
Comparisons of continuous variables were done by analysis of variance (ANOVA) with a repeated measure design. In case of global statistically significant differences, within-group (EST) changes were assessed by paired t tests with Bonferroni correction for multiple comparisons. SPSS version 12.02 statistical Figure 1 Study protocol. Patients with stable coronary artery disease underwent two kinds of exercise stress test (EST) protocol with 4-day interval from each other. In one of the 2 days of the study (A), patients underwent maximal treadmill EST (EST-1). In the other day (B), patients first underwent a low workload EST (p-EST), which was stopped at the ischemia threshold, and then, 45 minutes later, a maximal EST (EST-2). Blood samples were obtained before EST and at peak EST-1 and EST-2 (black arrows) to evaluate closure time (CT) by the platelet function analyser (PFA-100) method, and monocyteeplatelet aggregates (MPA) and CD41 mfi (CD41) by flow cytometry.
software was used for statistical analysis. Clinical and experimental data are reported as mean6SD. Table 1 shows the main clinical characteristics of patients included in the study (16 men, four women; aged 7169 years). Coronary angiography showed one-vessel, two-vessel and threevessel disease in 11 (55%), two (10%) and seven (35%) patients, respectively. All but two patients had undergone one or more revascularisation procedures. All patients were taking aspirin (100 mg a day).
RESULTS
Clinical characteristics
The main results of the EST performed during the study protocol are summarised in table 2. Significant ST-segment depression was induced during all tests. One patient only (5%) experienced angina during maximal EST (during both EST-1 and EST-2). No differences were found between EST-1 and EST-2 in heart-rate, systolic blood pressure and rate-pressure product at 1-mm ST-segment depression, as well as at peak exercise. Times to 1-mm ST depression and exercise duration were also similar.
Platelet reactivity at rest
Basal closure time, MPA and CD41-mfi did not differ before EST-1 and EST-2. A similar increase in MPA and CD41-mfi was observed after ADP stimulation before the two maximal EST (table 3) .
Platelet reactivity after exercise
A significant difference between EST-1 and EST-2 was observed in the response to exercise of closure time (p<0.001). Indeed, closure time decreased significantly after EST-1 (p<0.001) but not after EST-2 (p¼0.10) (figure 2). Compared with rest, closure time at peak exercise decreased by 17.368.4% and by 4.5612% after EST-1 and EST-2, respectively (p<0.0001).
A significant difference between EST-1 and EST-2 in the response to exercise was also observed for MPA (p¼0.03), but not for CD41-mfi (p¼0.39). MPA, in fact, increased significantly after EST-1 (p<0.05) but not after EST-2 (p¼0.40) (table 3) .
Of note, although ADP stimulation induced a significant increase in MPA and CD41-mfi after both EST-1 and EST-2, the level of the increase was significantly lower after EST-2 compared with EST-1 (p<0.001 for both) (figure 3).
Platelet reactivity after theophylline infusion
In the seven patients who underwent the theophylline substudy, EST parameters were similar for EST-1, EST-2 and EST-Th except for the time to 1 mm ST depression, which was significantly longer after theophylline administration (table 4) .
The main results of platelet reactivity observed in these patients are summarised in table 5. Closure time values, MPA and CD41-mfi (with and without ADP stimulation) after theophillyne administration and before EST-Th were similar to those measured before EST-1 and EST-2.
A significantly different closure time response to exercise was observed among EST-1, EST-2 and EST-Th (p<0.03) (figure 4). Indeed, as in the whole group of patients, closure time decreased significantly after EST-1 (p<0.001), but not after EST-2 (p¼0.76); however, a significant reduction in closure time compared with pre-exercise was observed after EST-Th (p<0.001). The changes in MPA and CD41-mfi in response to EST-1, EST-2 and EST-Th did not differ among groups. ADP stimulation after EST-1 and after EST-Th, however, induced a greater increase in MPA compared with EST-2 (p<0.001 for both). The changes in CD41-mfi after the three EST, with and without ADP stimulation, did not show any significant differences among groups, which might have been related to the small number of patients in this substudy (table 5) .
DISCUSSION
In this study, for the first time, we show that the significant increase in platelet reactivity induced by maximal EST in patients with obstructive CAD is significantly reduced by a short episode of myocardial ischaemia induced by low-workload exercise performed 45 minutes before maximal EST.
Furthermore, we provide some evidence that adenosine might play a role in this phenomenon, as this was prevented by administration of the adenosine antagonist theophylline.
Pathophysiological and clinical implications
Several previous studies have shown that patients with ST-segment elevation AMI who experience angina episodes in the hours or days preceding AMI onset have a smaller final infarct size and a better clinical course compared with those with no history of angina before AMI. 4 The protective effects of pre-infarction angina in this clinical setting is usually attributed to ischaemic preconditioning, 3 which acts by inducing metabolic changes in myocardial cells during the preconditioning ischaemic episodes, which make them more resistant to subsequent severe ischaemic insult. 1 2 Although myocardial protection by ischaemic preconditioning is likely to be a major mechanism for the clinical benefits of pre-infarction angina, these patients have also been shown to present a higher successful rate of coronary reperfusion following thrombolytic therapy, compared with patients without pre-infarction angina, 5 6 suggesting that they might also exhibit a reduced thrombogenic burden. In fact, Linden et al, 7 in
an experimental model showed that preconditioning ischaemia attenuated platelet reactivity to a damaged coronary artery wall, suggested that in the clinical setting the favourable effects of preinfarction ischaemia might also be mediated by a reduction in platelet reactivity. 7 8 Nevertheless, to the best of our knowledge, no clinical studies have assessed the effect of transient myocardial ischaemia on platelet reactivity in CAD patients.
Several studies have shown that exercise increases platelet reactivity in patients with CAD, 9e13 suggesting that this effect can contribute to the small but definite increased risk of acute coronary events related to exercise. 22e24 The mechanisms by which exercise increases platelet reactivity are probably multiple and may include an increase in circulating platelets, 25 an increase of intravascular shear stress, the presence of stenoses, 26 a reduced antiplatelet effect of dysfunctional endothelium in atherosclerotic vessels, 27 and increased catecholamine release that can stimulate platelet activation through a 2 -adrenoceptors. 28 Accordingly, in several recent studies we have consistently shown decreased closure time with exercise using the PFA-100 method, 11 12 18 19 which correlated with an increased expression of platelet membrane receptors (CD41 and P-selectin). 12 We also confirm these findings in the present study, in which we show an increased exercise-induced formation of MPA, which has also been suggested to be a sensitive marker of platelet activation 29 and to predict coronary events in CAD patients. 30 In this study we provide evidence that a short episode of myocardial ischaemia antagonises the enhanced platelet reactivity induced by maximal exercise in patients with stable obstructive CAD, 9e13 thus suggesting that this phenomenon might contribute to the beneficial consequences of pre-infarction angina.
It is worth noting that the effects of transient myocardial ischaemia were independent of any evidence of myocardial ischaemic preconditioning. Indeed, contrary to our expectations, in this study no improvement of exercise-induced ischaemia was found during the symptom-limited EST (EST-2) performed after the p-EST. The reasons for the lack of ischaemic preconditioning in this study are not completely clear; however, our protocol presented two major differences compared with previous studies that showed an improvement of myocardial ischaemia on the second of two consecutive EST, 14e16 which might have contributed, at least partly, to explain our failure to detect myocardial ischaemic preconditioning. First, in previous studies the second EST was usually performed 10e15 minutes after the first, whereas in this study it was performed 45 minutes after the first EST, a time that was chosen, on the basis of our previous data, to allow normalisation of closure time after the EST. 18 19 Second, in previous studies the first test was symptom-limited, whereas in the present study the p-EST was submaximal and stopped just as soon as ischaemic ST-segment changes appeared.
The mechanisms responsible for the prevention of the exercise-induced increase of platelet reactivity by a previous effort resulting in myocardial ischaemia remain to be fully elucidated. However, our observation that theophylline, a non-specific adenosine antagonist, was able to blunt this favourable effect suggests that adenosine may indeed play a role.
Adenosine is the main mediator of metabolic coronary blood flow regulation, and therefore is released in large amounts during myocardial ischaemia. 31 32 Adenosine, however, also has antiplatelet effects through A2 adenosine receptor stimulation 33e35 and, importantly, it is also believed to play a significant role in myocardial protection induced by ischaemic preconditioning. 36e38 We might thus speculate that adenosine released during a short myocardial ischaemic episode (as in our p-EST) might induce changes in the number/affinity of membrane receptors and/or in the intracellular signalling pathways of platelets that result in a reduction in the increased platelet reactivity after subsequent exercise-induced myocardial ischaemia.
Limitations of the study
Some questions following our study remain open. First, we show that ischaemic low-workload EST induces protection against a subsequent effort-related increase in platelet reactivity and monocyteeplatelet interaction. However, we cannot exclude that exercise per se, rather than EST-induced myocardial ischaemia, is responsible for this effect. Second, the time course of the protective effect of transient myocardial ischaemia on platelet reactivity remains to be established.
All our patients were on aspirin therapy, therefore we cannot exclude that different results might have been obtained without the antiplatelet effect of aspirin. However, due to ethical concerns, aspirin could not be withdrawn in our patients. Furthermore, the influence of aspirin on exercise-related changes in platelet reactivity may be limited. 18 39 40 It should be noted that aspirin is an obligatory treatment in CAD patients and, therefore, our data may have more relevant clinical implications than those that would have been obtained in the absence of aspirin treatment.
CONCLUSIONS
In this study we show that in patients with stable CAD, a short episode of myocardial ischaemia prevents the increase in platelet reactivity during subsequent symptom-limited effort, suggesting that this phenomenon might be involved in the favourable clinical effects of pre-infarction angina. Our data also suggest that adenosine might be involved in the mechanisms responsible for this beneficial phenomenon. and preconditioned exercise stress test after theophylline administration (EST-Th) in seven patients with coronary artery disease. MPA, monocyteeplatelet aggregates.
